"When a physician prescribes a compounded medication, a licensed pharmacist prepares it by adjusting an FDA-approved drug to create a tailored formulation when no commercial option meets the patient's needs. Simply put, compounding exists to fill gaps in care. This plays a critical role, for example, with oncology patients who require custom dosages not offered in commercial products, or those who need medications reformulated without allergens."
"Responsible compounding is always: Anchored in evidence, Only used when no FDA-approved option exists and patients would otherwise have no access, And part of a defined regulatory plan. When aligned with these standards, compounding can bring scientific advancements into real‑world use years sooner—without compromising rigor—especially in areas where investment and approvals lag."
Compounding—the practice of licensed pharmacists preparing tailored formulations of FDA-approved drugs—serves a legitimate clinical purpose when used responsibly to fill genuine care gaps. While some companies exploit compounding to bypass regulatory standards, responsible compounding requires evidence-based approaches, use only when no FDA-approved alternatives exist, and integration into defined regulatory pathways. Compounding plays critical roles in oncology for custom dosages and allergen-free formulations, and can deliver new formulations to underserved populations using proven ingredients. Women's health exemplifies an area where compounding can bridge urgent unmet needs and slow regulatory timelines, as this therapeutic category lags decades behind others in FDA-approved options.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]